Molecular biology and genetics of the angiotensin-I-converting enzyme: Potential implications in cardiovascular diseases

Cardiovascular Research

Volumn 32, Issue 6, 1996, Pages 999-1007

  Villard, Eric ^a   Soubrier, Florent ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

ACE activity; ACE gene; gene expression

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE;

ANIMAL CELL; CARDIOVASCULAR DISEASE; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC POLYMORPHISM; GENOTYPE; HEART FAILURE; HUMAN; HUMAN CELL; HYPERTENSION; MOLECULAR BIOLOGY; MOLECULAR GENETICS; NONHUMAN; PRIORITY JOURNAL; REVIEW;

CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; GENE EXPRESSION; HEART; HUMANS; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC;

EID: 0030476488     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(96)00170-8     Document Type: Review

References (83)

1. Erdös EG. Angiotensin I converting enzyme and the changes in our concepts through the years. Lewis K. Dahl memorial lecture. Hypertension. 16:1990;363-370.
2. Soubrier F, Alhenc-Gelas F, Hubert C, et al. Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proc Natl Acad Sci USA. 85:1988;9386-9390.
3. Lattion AL, Soubrier F, Allegrini J, Hubert C, Corvol P, Alhenc-Gelas F. The testicular transcript of the angiotensin I-converting enzyme encodes for the ancestral, non-duplicated form of the enzyme. FEBS Lett. 252:1989;99-104.
4. Ehlers MRW, Fox EA, Strydom DJ, Riordan JF. Molecular cloning of human testicular angiotensin-converting enzyme: The testis isozyme is identical to the C-terminal half of endothelial angiotensin-converting enzyme. Proc Natl Acad Sci USA. 86:1989;7741-7745.
5. Wei L, Alhenc-Gelas F, Corvol P, Clauser E. The two homologous domains of the human angiotensin I-converting enzyme are both catalytically active. J Biol Chem. 266:1991;9002-9008.
6. Wei L, Clauser E, Alhenc-Gelas F, Corvol P. The two homologous domains of human angiotensin I-converting enzyme interact differently with competitive inhibitors. J Biol Chem. 267:1992;13398-13405.
7. Perich RB, Jackson B, Rogerson F, Mendelsohn FAO, Paxton D, Johnston CI. Two ligand sites on angiotensin-converting enzyme: Evidence from radioligand binding studies. Mol Pharmacol. 42:1992;286-293.
8. Krege JH, John SWM, Langenbach LL, et al. Male-female differences in fertility and blood pressure in ACE-deficient mice. Nature. 375:1995;146-148.
9. Ryan US, Ryan JW, Whitaker C, Chiu A. Localization of angiotensin-converting enzyme (kininase II) II. Immunocytochemical and immunofluorescence . Tissue Cell. 8:1976;125-145.
10. Arnal J-F, Battle T, Rasetti C, et al. ACE in three tunicae of rat aorta: expression in smooth muscle and effect of renovascular hypertension. Am J Physiol. 267:1994;H1777-H1784.
11. Battle T, Arnal J-F, Challah M, Michel J-B. Selective isolation of rat aortic wall layers and their cell types in culture - Application to converting enzyme activity measurements. Tissue Cell. 26:1994;943-955.
12. Bruneval P, Hinglais N, Alhenc-Gelas F, et al. Angiotensin I converting enzyme in human intestine and kidney. Ultrastructural immunohistochemical localization. Histochemistry. 85:1986;73-80.
13. Arregui A, Iversen LL. Angiotensin-converting enzyme: presence of high activity in choroid plexus of mammalian brain. Eur J Pharmacol. 52:1978;147-150.
14. Cushman DW, Cheng HS. Concentrations of angiotensin-converting enzyme in tissues of rat. Biochim Biophys Acta. 250:1971;261-265.
15. Costerousse O, Allegrini J, Lopez M, Alhenc-Gelas F. Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem J. 290:1993;33-40.
16. Weinberg KS, Douglas WHJ, MacNamee DR, Lanzillo JJ, Fanburg BL. Angiotensin I-converting enzyme localization on cultured fibroblasts by immunofluorescence. In Vitro. 18:1982;400-406.
17. Barnes K, Matsas R, Hooper NM, Turner AJ, Kenny AJ. Endopeptidase 24.11 is striosomally ordered in pig brain and, in contrast to aminopeptidase N and dipeptidyl dipeptidase, an angiotensin converting enzyme, is a marker for a set of striatal efferent fibers. Neuroscience. 27:1988;799-817.
18. Yamada H, Fabris B, Allen AM, Jackson B, Johnston CI, Mendelsohn FAO. Localization of angiotensin converting enzyme in rat heart. Circ Res. 68:1991;141-149.
19. Sun Y, Weber KT. Tissue angiotensin converting enzyme (TACE) and myocardial remodeling after infarction. In: Abstracts, 15th Meeting of the International Society of Hypertension, Melbourne, March 1994:S187,1033.
20. Hubert C, Houot AM, Corvol P, Soubrier F. Structure of the angiotensin I-converting enzyme gene. Two alternate promoters correspond to evolutionary steps of a duplicated gene. J Biol Chem. 266:1991;15377-15383.
21. Testut P, Soubrier F, Corvol P, Hubert C. Functional analysis of the somatic angiotensin I converting enzyme promoter. Biochem J. 293:1993;843-848.
22. Goraya TY, Kessler SP, Kumar RS, Douglas J, Sen GC. Identification of positive and negative transcriptional regulatory elements of the rabbit angiotensin-converting enzyme gene. Nucl Acids Res. 22:1994;1194-1201.
23. Sibony M, Gasc J-M, Soubrier F, Alhenc-gelas F, Corvol P. Gene expression and tissue localization of the two isoforms of angiotensin I converting enzyme. Hypertension. 21:1993;827-835.
24. Nadaud S, Houot AM, Hubert C, Corvol P, Soubrier F. Functional study of the germinal angiotensin I-converting enzyme promoter. Biochem Biophys Res Commun. 189:1992;134-140.
25. Langford KG, Shai SY, Howard TE, Kovac MJ, Overbeek PA, Bernstein KE. Transgenic mice demonstrate a testis-specific promoter for angiotensin-converting enzyme. J Biol Chem. 266:1991;15559-15562.
26. Howard T, Balogh R, Overbeek P, Bernstein KE. Sperm-specific expression of angiotensin-converting enzyme (ACE) is mediated by a 91-base-pair promoter containing a CRE-like element. Mol Cell Biol. 13:1993;1-27.
27. Turner AJ, Hryszko J, Hooper NM, Dowdall MJ. Purification and characterization of a peptidyl dipeptidase resembling angiotensin converting enzyme from the electric organ of torpedo marmorata. J Neurochem. 48:1987;910-916.
28. Cornell MJ, Wiliams TA, Lamango LS, Coates D, Corvol P, Soubrier F, Hoheisel J, Lehrach H, Isaac RE. Cloning and expression of an evolutionary conserved single-domain angiotensin converting enzyme from Drosophila melanogaster. J Biol Chem. 270:1995;13613-13619.
29. Krulewitz AK, Fanburg BL. Stimulation of bovine endothelial cell angiotensin converting enzyme activity by cAMP related agents. J Cell Physiol. 129:1986;147-150.
30. Dasarathy Y, Fanburg BL. Involvement of second messenger systems in stimulation of angiotensin converting enzyme of bovine endothelial cells. J Cell Physiol. 148:1991;327-335.
31. Krulewitz AH, Baur WE, Fanburg BL. Hormonal influence on endothelial cell angiotensin-converting enzyme activity. Am J Physiol. 247:1984;C163-C168.
32. Fishel RS, Eisenberg S, Shai S-Y, Redden RA, Bernstein KE, Berk BC. Glucocorticoids induce angiotensin-converting enzyme expression in vascular smooth muscle. J Clin Invest. 25:1995;343-349.
33. Friedland J, Setton C, Silverstein E. Angiotensin converting enzyme induction by steroids in rabbit alveolar macrophages in culture. Science. 197:1977;64-65.
34. Friedland J, Setton C, Silverstein E. Induction of angiotensin-converting enzyme in human monocytes in culture. Biochem. Biophys Res Commun. 83:1978;843-849.
35. Fishel R, Thourani V, Eisenberg SJ, Shai SY, Corson MA, Nabel EG, Bernstein KE, Berk BC. Fibroblast growth factor stimulates angiotensin converting enzyme expression in vascular smooth muscle cells. J Clin Invest. 95:1995;377-387.
36. Kokubu TE, Ueda E, Ono M, Kawabe T, Hayashi Y, Kan T. Effects of captopril (SQ14,255) on the renin-angiotensin-aldosterone system in normal rats. Eur J Pharmacol. 62:1980;269-275.
37. Fyrhquist F, Florslund T, Tikkanen I, Gronhagen-Riska C. Induction of angiotensin-converting enzyme in rat lung with captopril (SQ 14225). Eur J Pharmacol. 67:1980;473-475.
38. Larochelle P, Genest J, Kuchel O, Roche R, Gutkowska Y, McKinstry D. Effect of captopril (SQ14225) on blood pressure, plasma renin activity and angiotensin I converting enzyme activity. Can Med Assoc J. 121:1979;309-316.
39. King SJ, Oparil S. Converting-enzyme inhibitors increase converting-enzyme mRNA and activity in endothelial cells. Am J Physiol. 263:1992;C743-C749.
40. Schunkert H, Dzau VJ, Tang SS, Hirsch AT, Apstein CS, Lorell BH. Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. J Clin Invest. 86:1990;1913-1920.
41. Hirsch AT, Talsness CE, Schunkert H, Paul M, Dzau VJ. Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure. Circ Res. 69:1991;475-482.
42. Shiota N, Miyazaki M, Okunishi H. Increase of angiotensin converting enzyme gene expression in the hypertensive aorta. Hypertension. 20:1992;168-174.
43. Challah M, Nicoletti A, Arnal JF, et al. Cardiac angiotensin converting enzyme overproduction indicates interstitial activation in renovascular hypertension. Cardiovasc Res. 30:1995;231-239.
44. Morrell NW, Atochina EN, Morris KG, Danilov SM, Stenmark KR. Angiotensin converting enzyme expression is increased in small pulmonary aretries of rats with hypoxia-induced pulmonary arteries. J Clin Invest. 96:1995;1823-1833.
45. Alhenc-Gelas F, Richard J, Courbon D, Warnet JM, Corvol P. Distribution of plasma angiotensin I-converting enzyme levels in healthy men;relationship to environmental and hormonal parameters. J Lab Clin Med. 117:1991;33-39.
46. Cambien F, Alhenc-Gelas F, Herbeth B, et al. Familial resemblance of plasma angiotensin-converting enzyme level: The Nancy Study. Am J Hum Genet. 43:1988;774-780.
47. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 86:1990;1343-1346.
48. Tiret L, Rigat B, Visvikis S, et al. Evidence from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet. 51:1992;197-210.
49. McKenzie CA, Julier C, Forrester T, et al. Segregation and linkage analysis of serum angiotensin I-converting enzyme levels: evidence for two quantitative-trait loci. Am J Hum Genet. 57:1995;1426-1435.
50. Villard E, Tiret L, Visvikis S, Rakotovao R, Cambien F, Soubrier F. Identification of new polymorphisms of the angiotensin I-converting enzyme (ACE) gene, and study of their relationship to plasma ACE levels by two-QTL segregation-linkage analysis. Am J Hum Genet. 58:1996;1268-1278.
51. Williams TA, Villard E, Soubrier F. A genetic study of angiotensin I-converting enzyme levels in human semen. Mol Cell Endocrinol. 107:1995;215-219.
52. Jeunemaitre X, Lifton R, Hunt SC, Williams RR, Lalouel JM. Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nature Genet. 1:1992;72-75.
53. Harrap SB, Davidson HR, Connor JM, et al. The angiotensin I-converting enzyme gene and predisposition to high blood pressure. Hypertension. 21:1993;455-460.
54. Higashimori K, Zhao Y, Higaki J, et al. Association analysis of a polymorphism of the angiotensin converting enzyme gene with essential hypertension in the japanese population. Biochem Biophys Res Commun. 2:1993;399-404.
55. Zee RYL, Lou YK, Griffiths LR, Morris BJ. Association of a polymorphism of the angiotensin I-converting enzyme gene with essential hypertension. Biochem Biophys Res Commun. 184:1992;9-15.
56. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:1993;801-809.
57. Powell JS, Clozel JP, Müller RKM, et al. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science. 245:1989;186-188.
58. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal angioplasty? The results of the MERCATOR study: a multicenter, randomized, double-blind, placebo-controlled trial. Circulation. 86:1992;100-111.
59. Cambien F, Poirier O, Lecerf L, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 359:1992;641-644.
60. Tiret L, Bonnardeaux A, Poirier O, et al. Synergistic effects on angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet. 344:1994;910-913.
61. Mattu RK, Needham EWA, Galton DJ, Frangos E, Clark AJL, Caufield M. A DNA variant at the angiotensin-converting enzyme gene locus associates with coronary artery disease in the Caerphilly heart study. Circulation. 91:1995;270-274.
62. Ruiz J, Blanché H, Cohen N, et al. Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA. 91:1994;3662-3665.
63. Tiret L, Kee F, Poirier O, et al. Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet. 341:1993;991-993.
64. Bohn M, Berge KE, Bakken A, Erikssen J, Berg K. Insertion/deletion (I/D) polymorphism at the locus for angiotensin I-converting enzyme and parental history of myocardial infarction. Clin Genet. 44:1993;298-301.
65. Badenhop RF, Wang XL, Wilcken DEL. Angiotensin-converting enzyme genotype in children and coronary events in their grandparents. Circulation. 91:1995;1655-1658.
66. Bohn M, Berge KE, Bakken A, Erikssen J, Berg K. Insertion/deletion (I/D) polymorphism at the locus for angiotensin I-converting enzyme and myocardial infarction. Clin Genet. 44:1993;292-297.
67. Lindpaintner K, Pfeffer MA, Kreutz R, et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med. 332:1995;706-711.
68. Schunkert H, Hans-Werner H, Holmer SR, et al. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med. 330:1994;1634-1638.
69. Iwai N, Ohmichi N, Nakamura Y, Kinoshita M. DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation. 90:1994;2622-2628.
70. Montgomery H, Clarkson P, Dollery C, et al. D polymorphism of the angiotensin-converting enzyme gene is strongly associated with the development of physiological ventricular hypertrophy. J. Am Coll Cardiol. 244A:1996;970-120.
71. Bonithon-Kopp C, Ducimetière P, Touboul PJ, et al. Plasma angiotensin-converting enzyme activity and carotid wall thickening. Circulation. 89:1994;952-954.
72. Castellano M, Muiesan M-L, Rizzoni D, et al. Angiotensin-converting enzyme I/D polymorphism and arterial wall thickness in a general population. The Vobarno Study. Circulation. 91:1995;2721-2724.
73. Danser AHJ, Koning MMG, Admiraal PJJ, Derkx FHM, Verdouw PD, Schalekamp MADH. Metabolism of angiotensin I by different tissues in the intact animal. Am J Physiol. 263:1992;H418-H428.
74. Lachurié M-L, Azizi M, Guyene T-T, Alhenc-Gelas F, Ménard J. Angiotensin-converting enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in normotensive subjects. Circulation. 91:1995;2933-2942.
75. Ueda S, Elliott HL, Morton JJ, Connell JMC. Enhanced pressor response to angiotensin I in normotensive men with the deletion genotype (DD) for angiotensin-converting enzyme. Hypertension. 25:1995;1266-1269.
76. Morishita R, Gibbons GH, Ellison KE, et al. Evidence for direct local effect of angiotensin in vascular hypertrophy. In vivo gene transfer of angiotensin converting enzyme. J Clin Invest. 94:1994;978-984.
77. von der Leyen HE, Gibbons GH, Morishita R, et al. Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci USA. 92:1995;1137-1141.
78. Moncada RS, Palmer RMJ, Higgs EA. Generation of prostacyclin and endothelium-derived relaxing factor from endothelial cells. In: Jolles G, Legrand JY and Nurden A. Biology and Pathology of Platelet-Vessel Wall Interactions. London: Academic Press. 6:1986;289-304.
79. Danser AHJ, Schalekamp MADH, Bax WA, Maassen van den Brink A, Saxena PR, Riegger GAJ, Schunkert H. Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation. 92:1995;1387-1888.
80. Sadoshima J-I, Xu Y, Slayter HS, Izumo S. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell. 75:1993;977-984.
81. Houghton JL, Carr AA, Prisant LM, Rogers WB, Von Dohlen TW, Flowers NC. Morphologic, hemodynamic and coronary perfusion characteristics in severe left ventricular hypertrophy secondary to systemic hypertension and evidence for non atherosclerotic myocardial ischemia. Am J Cardiol. 69:1992;219-224.
82. Polese A, DeCesare N, Montorsi P, Fabriochi F, Guazzi M, Loaldi A. Upward shift of the lower range of coronary flow autoregulation in hypertensive patients with hypertrophy of the left ventricle. Circulation. 83:1991;845-853.
83. Gibson G, Hogness DS. Effect of polymorphism in the Drosophila regulatory gene Ultrabithorax on homeotic stability. Science. 271:1996;200-203.